MARON BARRACLOUGH: Open Payments
NPI 1649723289 · BATAVIA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$711 in 48 payments from 9 companies in 2025. Trend: 2023 $446 · 2024 $787 · 2025 $711
Food & beverage: $711
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 37 | $505 |
| AstraZeneca Pharmaceuticals LP | 3 | $63 |
| GlaxoSmithKline, LLC. | 2 | $32 |
| Lilly USA, LLC | 1 | $20 |
| Exact Sciences Corporation | 1 | $20 |
| Dexcom, Inc. | 1 | $19 |
| E.R. Squibb & Sons, L.L.C. | 1 | $19 |
| Seqirus USA Inc | 1 | $18 |
| Amgen Inc. | 1 | $14 |
Products named: Ozempic, Rybelsus, Wegovy, AIRSUPRA, TRELEGY ELLIPTA, FARXIGA, ZEPBOUND, Cologuard Collection Kit.
Industry payments across NY — which companies pay providers there.
